Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Toxin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103554226B details all-solid-phase synthesis for alpha-conotoxin MI. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114230653B reveals a novel fragment coupling method for Chlorotoxin, achieving >99% purity. Discover cost-effective manufacturing strategies for this tumor-targeting peptide intermediate.
Patent CN107531680B reveals a novel route for toxin intermediates, offering high optical purity and yield for cost reduction in ADC toxin manufacturing.